Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Breast Neoplasms 3Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1

Interventions

Taxes 2Paclitaxel 2Oxaliplatin 2Magnesium Sulfate 2Carboplatin 2Calcium Gluconate 2haloperidol decanoate 1glutamic acid diethyl ester 1axicabtagene ciloleucel 1Vitamin E 1Vincristine 1Thalidomide 1Surveys and Questionnaires 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Procarbazine 1Peripheral Blood Stem Cell Transplantation 1Pain Management 1Modafinil 1Methotrexate 1Memantine 1Melphalan 1Lorazepam 1Leucovorin 1Lamotrigine 1Ketamine 1Interleukin 1 Receptor Antagonist Protein 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurotoxicity Syndromes × Duloxetine Hydrochloride × Clear all
NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡